Klaudia Rydzyńska

Ms. Klaudia Rydzyńska

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AKAndrzej Konieczny
Andrzej Konieczny
JSJakub Stojanowski
Jakub Stojanowski
KRKlaudia Rydzyńska
Klaudia Rydzyńska
MKMariusz Kusztal
Mariusz Kusztal
MKMagdalena Krajewska
Magdalena Krajewska
Delayed-graft function (DGF) might be responsible for shorter graft survival. Therefore, a clinical tool predicting its occurrence is vital for the risk assessment of transplant outcomes. In a single-center study, we conducted data mining and machine learning experiments, resulting in DGF predictive models based on random forest classifiers (RF) and an artificial neural network called multi-layer perceptron (MLP). All designed models had four common input parameters, determining the best accuracy and discriminant ability: donor’s eGFR, recipient’s BMI, donor’s BMI, and recipient–donor weight difference. RF and MLP designs, using these parameters, achieved an accuracy of 84.38% and an area under curve (AUC) 0.84. The model additionally implementing a donor’s age, gender, and Kidney Donor Profile Index (KDPI) accomplished an accuracy of 93.75% and an AUC of 0.91. The other configuration with the estimated post-transplant survival (EPTS) and the kidney donor risk profile (KDRI) achieved an accuracy of 93.75% and an AUC of 0.92. Using machine learning, we were able to assess the risk of DGF in recipients after kidney transplant from a deceased donor. Our solution is scalable and can be improved during subsequent transplants. Based on the new data, the models can achieve better outcomes.

Verified
Journal Article
Open access
PDF file
JSJakub Stojanowski
Jakub Stojanowski
AKAndrzej Konieczny
Andrzej Konieczny
ŁLŁukasz Lis
Łukasz Lis
WFWeronika Frosztęga
Weronika Frosztęga
PBPatrycja Brzozowska
Patrycja Brzozowska
MKMagdalena Krajewska
Magdalena Krajewska
The majority of recently published studies indicate a greater incidence and mortality due to Clostridioides difficile infection (CDI) in patients with chronic kidney disease (CKD). Hospitalization, older age, the use of antibiotics, immunosuppression, proton pump inhibitors (PPI), and chronic diseases such as CKD are responsible for the increased prevalence of infections. The aim of the study is to identify clinical indicators allowing, in combination with artificial intelligence (AI) techniques, the most accurate assessment of the patients being at elevated risk of CDI.